287 related articles for article (PubMed ID: 19393822)
1. Treatment of patients with hypertension and arthritis pain: new concepts.
Weber MA
Am J Med; 2009 May; 122(5 Suppl):S16-22. PubMed ID: 19393822
[TBL] [Abstract][Full Text] [Related]
2. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
Fiorucci S; Santucci L; Distrutti E
Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
[TBL] [Abstract][Full Text] [Related]
3. Defining the problem of treating the patient with hypertension and arthritis pain.
White WB
Am J Med; 2009 May; 122(5 Suppl):S3-9. PubMed ID: 19393824
[TBL] [Abstract][Full Text] [Related]
4. Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis.
White WB; Schnitzer TJ; Fleming R; Duquesroix B; Beekman M
Am J Cardiol; 2009 Sep; 104(6):840-5. PubMed ID: 19733721
[TBL] [Abstract][Full Text] [Related]
5. Treatment of osteoarthritis in hypertensive patients.
Mackenzie IS; MacDonald TM
Expert Opin Pharmacother; 2010 Feb; 11(3):393-403. PubMed ID: 20059368
[TBL] [Abstract][Full Text] [Related]
6. The potential role of nitric oxide in cardiovascular safety when treating patients with osteoarthritis and hypertension: a moderated panel discussion.
White WB; Pepine CJ; Weber MA
Am J Med; 2009 May; 122(5 Suppl):S23-5. PubMed ID: 19393823
[No Abstract] [Full Text] [Related]
7. Arthritis and drug therapy in the hypertension clinic.
Waller PC; Ramsay LE
Biomed Pharmacother; 1988; 42(3):207-11. PubMed ID: 3052606
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis.
Wallace JL; Viappiani S; Bolla M
Trends Pharmacol Sci; 2009 Mar; 30(3):112-7. PubMed ID: 19230986
[TBL] [Abstract][Full Text] [Related]
9. The potential role of nitric oxide in cardiovascular safety when treating osteoarthritis in patients with hypertension. Introduction.
White WB
Am J Med; 2009 May; 122(5 Suppl):S1-2. PubMed ID: 19393820
[No Abstract] [Full Text] [Related]
10. New nitric oxide-donating drugs for the treatment of airway diseases.
Lagente V; Advenier C
Curr Opin Investig Drugs; 2004 May; 5(5):537-41. PubMed ID: 15202728
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety, and tolerability of the cyclooxygenase-inhibiting nitric oxide donator naproxcinod in treating osteoarthritis of the hip or knee.
Karlsson J; Pivodic A; Aguirre D; Schnitzer TJ
J Rheumatol; 2009 Jun; 36(6):1290-7. PubMed ID: 19411388
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs and hypertension.
Zheng L; Du X
Cell Biochem Biophys; 2014 Jun; 69(2):209-11. PubMed ID: 24242190
[TBL] [Abstract][Full Text] [Related]
13. The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia.
Rigas B
Curr Opin Gastroenterol; 2007 Jan; 23(1):55-9. PubMed ID: 17133086
[TBL] [Abstract][Full Text] [Related]
14. NSAIDs & antihypertensives: an unhappy union.
Kozuh JL
Am J Nurs; 2000 Jun; 100(6):40-2; quiz 43. PubMed ID: 10892325
[No Abstract] [Full Text] [Related]
15. Development of novel agents based on nitric oxide for the control of colon cancer.
Kozoni V; Rosenberg T; Rigas B
Acta Pharmacol Sin; 2007 Sep; 28(9):1429-33. PubMed ID: 17723176
[TBL] [Abstract][Full Text] [Related]
16. Managing arthritis pain amid evolving science on pain relievers.
Dis Manag Advis; 2005 May; 11(5):58-9, 49. PubMed ID: 16013657
[TBL] [Abstract][Full Text] [Related]
17. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
Vardeny O; Solomon SD
Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
[TBL] [Abstract][Full Text] [Related]
19. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
Pronko TP; Zinchuk VV
Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
[TBL] [Abstract][Full Text] [Related]
20. Arthritis is associated with cardiovascular disease in the users of analgesics and nonsteroidal anti-inflammatory drugs.
Jamali F
Arch Intern Med; 2007 Nov; 167(21):2371-2; author reply 2372. PubMed ID: 18040003
[No Abstract] [Full Text] [Related]
[Next] [New Search]
